KCAS Bio is proud to announce our attendance at AD/PD 2025, Advances in Science & Therapy, taking place in Vienna, Austria, from April 1-5, 2025. This globally recognized conference brings together leading researchers, clinicians, and industry professionals to address the challenges of Alzheimer’s Disease (AD), Parkinson’s Disease (PD), and related…

KCAS Bio is excited to announce our participation in the Boston Society Gene and Cell Therapy Conference, taking place in Cambridge, Massachusetts, on March 20-21, 2025. This premier event gathers leading experts, innovators, and researchers to explore the latest advancements in gene and cell therapy. We are proud to contribute…

KCAS Bio is delighted to announce our participation in the 15th Annual World ADC, taking place in London, United Kingdom, from March 3-6, 2025. This premier event brings together the brightest minds in the field of antibody-drug conjugates (ADCs) to explore the latest scientific advancements, strategies, and technologies shaping the…

KCAS Bio is excited to announce our attendance at the 16th Open Scientific EIP (European Immunogenicity Platform) Symposium, taking place in Lisbon, Portugal, from February 24-26, 2025. This premier event brings together global leaders in immunogenicity to share insights, exchange ideas, and drive innovation in the development of biologics and…

KCAS Bio is proud to announce our participation in the 20th Congress of ECCO (European Crohn’s and Colitis Organisation), taking place in Berlin, Germany, from February 19-22, 2025. This prestigious event brings together global experts, researchers, and clinicians dedicated to improving the understanding and treatment of inflammatory bowel diseases (IBD).

KCAS Bio is excited to announce our participation in the Society of Toxicology (SOT) Annual Meeting and ToxExpo, taking place in Orlando, Florida on March 16th-20th. As one of the largest gatherings of toxicologists and life sciences professionals, this event offers a unique platform to connect with leaders in toxicology…

Dose Formulation Analysis is an essential step in regulated nonclinical studies. Robust analytical methods, rapid turnaround, and efficient communication helps ensure the dose form results for your GLP studies are delivered on time. At KCAS Bio, our scientific expertise allows us to develop methods that achieve…

As the bioanalytical market evolves at a rapid pace, KCAS Bio stands at the forefront, offering an innovative approach to challenges and opportunities alike. Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with…

Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…

Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…

KCAS Bio is excited to sponsor the upcoming Pharmaceutical & BioScience Society (PBSS) workshop “Antibody-Drug Conjugates from Discovery to Development: Chemistry, Engineering, Characterization, CMC, PK/Tox, Clinical Design and Intellectual Property,” on December 10th from 8:45am – 5:30pm PST in San Diego, California at the Hyatt Regency – La Jolla. Showcasing…

This infographic explores the key trends in flow cytometry, software and instrumentation based on results from a recent Spotlight survey. It highlights the top challenges for biomarker analysis using flow cytometry, including lack of standardized control materials, sourcing a suitable laboratory and uncertain regulatory expectation, as well as what the…